Research On The Priapus Shot

Research

Research Papers & Articles on Men’s Health reproduced from https://priapusshot.com/research/

Priapus Shot® for improved erectile function and for Peyronie’s
Priapus Shot® (P-Shot®) procedure for growth
Priapus Shot® procedure helps regenerate new nerve (post prostate surger y)
More research showing how PRP prepared and used properly can facilitate new nerve growth (for improved sensation and function).
Priapus Shot® procedure first suggested as possibility (“growth factors) in J Urol 2003
Treating BXO (lichen sclerosus) with the Priapus Shot® procedure
Peyronie’s Disease. This text gives an excellent review of the various treatments for Peyronie’s disease. It was written 5 years after the Priapus Shot® procedure was invented. Page 164 refers to the Priapus Shot® procedure.
With surgery, “recurrence and ED rates[s] are high and some patients may experience permanent loss of sensation.” “…not acceptable to many patients because the ‘loss’ of penile length.”
Combination therapy works better than one therapy alone (there can be a synergy).
Pump therapy corrected 51% of men-– satisfied with pump therapy alone (10 minutes twice a day). They did no other therapy in combination with the pump. Side effect was increase in length. This study in rats shows why the pump may help.
CoQ10 in double blind study.
Vitamin E. 1,200 IU daily.
Platelet rich plasma plasma for fibrosis and scar treatment.
Platelet rich plasma for autoimmune.
Platelet rich plasma for lichen sclerosus.
PRP supporting Priapus Shot® for Peyronie’s Disease
Another study indicating that the Priapus Shot® could be more beneficial and with fewer side effects than Xiapex for Peyronie’s
Correct deficiency to help Peyronie’s. Here’s a link to all the tests I normally do.
Walking associated with decreased inflammation and improved erection. For full benefit, it’s best if the man works up to 21-25 miles per week.
Cialis daily alone or in combination.
Safety Information about Xiaflex (collagenase).
Notice that the rate of ED is 0.4% in placebo and 1.8% in the Xiaflex group
–> So, the implied incidence of ED from Xiafex would be 1.8 – 0.4 = 1.4% Also, note that the rate of known rupture from Xiaflex is 0.5%. The rate of possible rupture (heard a popping sound or extensive bruising, etc.) was 0.9%.
0.5 + 0.9 = 1.4% (click here to see the warning box). So, both of those stats support a rate of rupture/ED secondary to Xiaflex would be around 1.4% or 1 in 70.